Ophthalmology · Ocular Pharmacology and Therapeutics (Anti-VEGF, Anti-glaucoma Classes, Steroids)

A 58-year-old man with moderate persistent asthma has newly diagnosed primary open-angle glaucoma. His physician wants a topical beta-blocker with the least risk of bronchospasm. Which agent is most appropriate?

  • A Timolol maleate 0.5%
  • B Levobunolol 0.5%
  • C Betaxolol 0.25%
  • D Carteolol 1%
Correct answer: C. Betaxolol 0.25%

Explanation

Betaxolol is a relatively cardioselective beta-1 antagonist, so it produces less blockade of pulmonary beta-2 receptors than non-selective agents such as timolol, levobunolol and carteolol. It therefore carries a lower, though not zero, risk of bronchospasm and remains the preferred beta-blocker when one must be used in a patient with reactive airway disease. Its IOP-lowering efficacy is slightly weaker than timolol.

Reference: Katzung, Basic and Clinical Pharmacology, 16th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Ocular Pharmacology and Therapeutics (Anti-VEGF, Anti-glaucoma Classes, Steroids) MCQs

See all Ocular Pharmacology and Therapeutics (Anti-VEGF, Anti-glaucoma Classes, Steroids) MCQs →